Shandong Buchang Pharmaceuticals Co (SHSE:603858) YoY EPS Growth : -74.76% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Shandong Buchang Pharmaceuticals Co's YoY EPS Growth for the quarter that ended in Mar. 2024 was -74.76%.

Shandong Buchang Pharmaceuticals Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.10.

Shandong Buchang Pharmaceuticals Co YoY EPS Growth Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co YoY EPS Growth Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

5.44

-3.50

-37.55

-231.59

120.82

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															5.91	-25.07	-60.10	78.33	-74.76

Shandong Buchang Pharmaceuticals Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Shandong Buchang Pharmaceuticals Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(0.288	-	-1.383)	/	\| -1.383 \|
=	120.82 %

Shandong Buchang Pharmaceuticals Co's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(0.104	-	0.412)	/	\| 0.412 \|
=	-74.76 %

Shandong Buchang Pharmaceuticals Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines